Daily Stock List
LifeLogger Technologies Corp. (LOGG)
SuperNova Elite, TopStockAnalysts, and StreetAuthority Daily reported recently on LifeLogger Technologies Corp. (LOGG), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
LifeLogger Technologies Corp.’s commitment is to changing the way people remember their life. The OTCQB-listed Company creates a unique user experience through combining video, face, text, GPS map, and OCR and voice recognition. This is to make the digital story of one’s life richer, fuller, accessible, searchable, as well as truly memorable. LifeLogger Technologies has its headquarters in Palm Beach Gardens, Florida.
LifeLogger Technologies is an innovative wearable technology and software company. It is developing the new standard for people to record, store and recall life's unique memories. This is achieved by way of its cloud based portal for video management, post video processing, easy search, live streaming and social sharing. The Company is working on creating the ultimate life logging system, equipped with a cloud solution and metadata processing software. This will actively store a person’s memories and make them available on the web, desktop and all of one’s mobile devices.
Its software seamlessly and automatically organizes videos by date, time, place or person on the Company’s own 3D timeline when uploaded to LifeLogger’s cloud based service. One will immediately be able to search their video library by any of these tags. One can instantly connect and share any of these videos with their friends on all social media.
To launch its hardware and software platforms for commercial use, LifeLogger is finishing the hardware design of its LifeLogger wearable camera. It is working with a leader in the field of consumer electronics cameras and is aiming to get into serial production of its camera in Q1 2015.
Moreover, LifeLogger is working on completing and upgrading the existing cloud based platform for storing, managing and displaying videos. The Company is starting with its 3D video timeline and adding Video Stabilization, Geo Tagging, Custom in video tags, Face detection, OCR, voice detection, live streaming and social sharing.
LifeLogger is working to complete the development of its video cloud storage solution featuring Android and IOS APP. In addition, LifeLogger is completing an open API to make it possible for other wearable cameras on the market to communicate with its cloud. This will make its cloud based video management available to a host of users upon public launch.
LifeLogger Technologies Corp. (LOGG), closed Thursday's trading session at $0.62, down 1.90%, on 333,581 volume with 207 trades. The average volume for the last 60 days is 243,285 and the stock's 52-week low/high is $0.10/$1.10.
Vertical Computer Systems, Inc. (VCSY)
Stockpalooza, StockHotTips, and Stockwatch 411 reported on Vertical Computer Systems, Inc. (VCSY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Vertical Computer Systems, Inc. is a global provider of complementary and integrated application software, cloud-based and software services, Internet core technologies, and intellectual property (IP) assets by way of its distribution network with operations or sales in the U.S., Canada, and Brazil. The Company’s main administrative software product is emPath®. Vertical Computer Systems is based in Richardson, Texas and the Company’s shares trade on the OTC Markets’ OTCQB.
Vertical Computer Systems’ business model combines complementary, integrated software products, internet core technologies, and a multinational distribution system of partners. This is to create a distribution matrix that it believes can penetrate numerous sectors via cross promotion.
The design of its emPath® is to handle complex Payroll and Human Resources challenges. It is a fully web-based HRMS solution. emPath® provides full administrative and workflow capabilities, and employee empowerment through employee and manager self-service. emPath® is developed, marketed, and maintained by NOW Solutions, Inc.
Vertical Computer Systems’ primary Internet core technologies include SiteFlash™, and the Emily XML™ Scripting Language, which can be used to build web services. Its SiteFlash™ technology utilizes XML and publishes on the web. This enables the user to build and efficiently operate websites with the distinct ability to separate form, function, as well as content.
Moreover, the Company offers its ResponseFlash™. This is a high-end software package. It offers a secure, integrated, complete solution for government agencies, which have a need to provide rapid response systems to other agencies and departments.
Vertical Computer Systems’ chief focus is to take advantage of the strength of its products including SiteFlash™, and emPath®, to its existing network of customers and vendors. Vertical also works to enter into co-marketing agreements with other companies whose products are proven and best of breed; profitable or on the path to profitability; complement each other, and provide cross-product distribution channels.
The Company’s Emily™ technology provides unique software for e-commerce, information technologies, web-based data management, and process control. The central component of the Emily™ technology is the powerful MLE Markup Language Executive. This is a patent pending, extensible, multi-platform scripting language with built-in parsing of XML and HTML data. This includes support for SQL databases.
Vertical Computer Systems, Inc. (VCSY), closed Thursday's trading session at $0.0154, up 6.21%, on 13,024,204 volume with 75 trades. The average volume for the last 60 days is 4,302,681 and the stock's 52-week low/high is $0.003/$0.0425.
Catasys, Inc. (CATS)
Greenbackers and RedChip reported earlier on Catasys, Inc. (CATS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed Catasys, Inc. is a provider of proprietary health management services to health insurers and employers. The Company provides specialized health management services via a network of licensed and company managed health care providers. Catasys formed to serve health care payors, and the Company provides unique and integrated substance dependence treatment solutions for its members. Its senior management team has 50-plus years of substance dependence experience and 100-plus years of health care experience. Catasys is headquartered in Los Angeles, California.
The Catasys substance dependence program improves member health, consequently lowering overall costs. The proprietary program addresses substance dependence as a chronic disease. The program focuses on the whole health of the member. The program delivers integrated medical and psychosocial interventions in combination with long-term care coaching.
The design of the Company’s OnTrak program is to improve member health and concurrently lower costs to the insurer through employing patient centric treatment, which integrates evidence based medical and psychosocial interventions along with care coaching in a 52-week outpatient program.
Currently, Catasys provides its proprietary OnTrak integrated substance dependence solutions for third-party payors in Kansas, Kentucky, Louisiana, Massachusetts, Oklahoma, West Virginia, Florida, and Wisconsin. OnTrak is improving member health and, simultaneously, is demonstrating reduced inpatient and emergency department utilization driving a greater than 50 percent reduction in total health care costs for enrolled members.
Catasys, in August 2014, signed an amendment to an existing contract with one of the largest insurance providers in the nation. This expands the availability of OnTrak to the provider's commercial members in Florida.
Recently, Catasys announced its financial results for Q3 ended September 30, 2014. Selected highlights include a 63 percent increase in Q3 enrollment versus the same quarter the year prior. Highlights also include a 239 percent increase in recognized revenue to $370,000 in Q3, versus the same quarter the year prior. Increased total revenues are mainly a result of an increase in health plans covered and enrollment growth, versus the same quarter in 2013.
Catasys, Inc. (CATS), closed Thursday's trading session at $2.39, up 3.91%, on 24,583 volume with 48 trades. The average volume for the last 60 days is 1,854 and the stock's 52-week low/high is $0.77/$2.45.
CytoDyn, Inc. (CYDY)
PennyStockRumors and AllPennyStocks reported earlier on CytoDyn, Inc. (CYDY), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
CytoDyn, Inc. is a biotechnology company with headquarters in Vancouver, Washington. The Company is concentrating on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and prevention of Human Immunodeficiency Virus (HIV). CytoDyn has one of the leading mAbs under development for HIV infection - PRO 140. This is a Late Stage 2 humanized mAb with demonstrated antiviral activity in humans. CytoDyn’s shares trade on the OTC Markets’ OTCQB.
PRO 140 is a humanized monoclonal antibody directed against CCR5, a molecular portal that HIV uses to enter cells. PRO 140 belongs to a new class of HIV/AIDS therapeutics - viral-entry inhibitors. The intention of these are to protect healthy cells from viral infection. PRO 140 blocks the HIV co-receptor CCR5. Clinical trial results so far indicate that it does not affect the normal function of the cell.
PRO 140 has been the subject of four Phase 1/1b and two Phase 2a clinical trials. Results from Phase 1/1b and Phase 2a human clinical trials have shown that PRO 140 can substantially reduce viral burden in people infected with HIV. CytoDyn’s intention is to continue to develop PRO 140 as a therapeutic anti-viral agent in persons infected with HIV.
PRO 140 has also been designated a "fast track" product candidate by the Food and Drug Administration (FDA). The PRO 140 antibody appears to be a powerful antiviral agent leading to potentially fewer side effects and less frequent dosing requirements in comparison to daily drug therapies presently in use.
CytoDyn announced in May 2014 that it dosed the first patients in its Phase 2b clinical trial with its lead product candidate, PRO 140. This trial is a treatment substitution protocol for patients with Human Immunodeficiency Virus (HIV). The principal goal for this Phase 2b trial is to assess the efficacy of PRO 140 monotherapy for the maintenance of viral suppression in HIV patients who are stable on combination antiretroviral therapy, called HAART (highly active antiretroviral therapy), but need or wish to discontinue HAART therapy temporarily.
This past October, CytoDyn announced the continuation of strong positive results for four weeks of monotherapy with its monoclonal antibody, PRO 140, in patients with HIV-1, who are presently participating in CytoDyn’s Phase 2b treatment substitution trial. The results from the treatment substitution trial to date have demonstrated 100 percent success in suppressing the viral load among patients who had weekly injections of PRO 140 for 4 weeks of monotherapy (success defined as zero virologic failures). CytoDyn is requesting FDA clearance to conduct a larger similar Phase 3 licensing trial to demonstrate further the efficacy of PRO 140 for 4 weeks of monotherapy with PRO 140.
CytoDyn, Inc. (CYDY), closed Thursday's trading session at $1.14, up 1.79%, on 138,494 volume with 51 trades. The average volume for the last 60 days is 81,671 and the stock's 52-week low/high is $0.54/$1.30.
Chuma Holdings, Inc. (CHUM)
TopPennyStockMovers reported recently on Chuma Holdings, Inc. (CHUM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Chuma Holdings, Inc. and its wholly-owned subsidiaries provide turnkey financing and support solutions to the rapidly evolving and growing legal cannabis industry. The Company’s experienced management team has a combined 35 years of successful experience in the legal cannabis industry in the State of California. Chuma provides "seed to sale" key business services. The Company lists on the OTC Bulletin Board.
Chuma Holdings is planning on expanding throughout California. It is also planning on bringing its collection of services to each new state that legalizes the use of cannabis.
Chuma’s "seed to sale" key business services include funding & financing solutions, compliance consulting, and retail, collective and dispensary solutions. Its services also include commercial build out and equipment solutions, supply chain solutions, branding, marketing and sales solutions, as well as banking and payment processing solutions.
Furthermore, its services include research & development (R&D) solutions and consumer product solutions. The Company is presently generating revenue from existing financing and service solutions.
This past November, Chuma Holdings announced it acquired Paul Shively & Associates, Inc. (PSA). PSA is an industry leader in corporate compliance in the legal cannabis industry. In the California medical marijuana field, PSA brings seven years of expertise in the design, operation, compliance and required day-to-day mandates required to run a legal collective, production and product company in California.
Acquiring PSA provides Chuma Holdings the intellectual property (IP) Mr. Shively and his team have created over the last seven years. The Company indicates that this IP includes trade secrets and business best practices specific to the marijuana industry and vital to the execution of the Chuma business strategy.
In addition, in November, Chuma Holdings announced that it contracted Capital Canada Limited to act as the Company’s exclusive Canadian Financial Advisor in connection with raising equity financing for Chuma from Canadian investors. Capital Canada is a recognized leader in providing investment banking services to mainly mid-market companies.
Chuma Holdings, Inc. (CHUM), closed Thursday's trading session at $1.13, up 10.78%, on 545,677 volume with 534 trades. The average volume for the last 60 days is 4,796 and the stock's 52-week low/high is $0.65/$6.99.
Amarantus BioScience Holdings, Inc. (AMBS)
BUYINS.NET, SuperNova Elite, Stock Analyzer, Streetwise Reports, PennyStocks24, Pumps and Dumps, Pennybuster, and SmallCapVoice reported earlier on Amarantus BioScience Holdings, Inc. (AMBS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
A biotechnology company, Amarantus BioScience Holdings, Inc. focuses on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration, and apoptosis. It is developing certain biologics surrounding the intellectual property (IP) and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, and other human diseases. Amarantus BioScience is based in San Francisco, California and the Company lists on the OTCQB.
Amarantus has an exclusive worldwide license to the Lymphocyte Proliferation test (LymPro Test®) for Alzheimer's disease. It has also licensed Eltoprazine, a phase 2b ready indication for Parkinson's Levodopa induced dyskinesia and Adult ADHD.
Furthermore, the Company owns the IP rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF). It is developing MANF-based products as treatments for brain disorders. Its lead therapeutic program MANF is a targeted therapeutic to address the underlying Programmed Cell Death (Apoptosis) associated with a broad spectrum of devastating human disorders.
Additionally, Amarantus BioScience owns IP for the diagnosis of Parkinson's disease (NuroPro) and the discovery of neurotrophic factors (PhenoGuard™). The Company is a Founding Member of the Coalition for Concussion Treatment (#C4CT). This movement began in collaboration with Brewer Sports International (BSI). It is working to raise awareness of new treatments in development for concussions and nervous-system disorders.
Recently, Amarantus BioScience Holdings announced positive effects of Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF) for the protection from vision loss in an animal model of retinitis pigmentosa (RP). MANF was discovered using the Company’s proprietary PhenoGuard™ Protein Discovery Engine.
On December 23, 2014, Amarantus BioScience announced that the U.S. Food and Drug Administration (FDA) granted Amarantus’ investigational drug MANF (mesencephalic-astrocyte-derived neurotrophic factor) orphan drug designation for the treatment of Retinitis Pigmentosa (RP). RP refers to a group of inherited diseases causing retinal degeneration often leading to blindness.
The FDA Orphan Drug Designation program provides a special status to drugs and biologics intended to treat, diagnose or prevent so-called orphan diseases and disorders that affect less than 200,000 people in the United States. The designation provides for a seven-year marketing exclusivity period against competition, and certain incentives. These incentives include federal grants, tax credits, as well as a waiver of Prescription Drug User Fee Act (PDUFA) filing fees.
Amarantus BioScience Holdings, Inc. (AMBS), closed Thursday's trading session at $0.0815, up 0.62%, on 4,125,729 volume with 219 trades. The average volume for the last 60 days is 2,902,457 and the stock's 52-week low/high is $0.0489/$0.196.
Solar Wind Energy Tower, Inc. (SWET)
PennyStocks24, Pumps and Dumps, PennyStocks Forever, and TheMicrocapNews reported earlier on Solar Wind Energy Tower, Inc. (SWET), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Solar Wind Energy Tower, Inc. (SWET) focuses on the design, development, and construction of Solar Wind Downdraft Towers. These towers use benevolent and non-toxic natural elements to produce electricity and clean water in the U.S. and worldwide. The Company has filed several patents that it believes will further enhance its pioneering technology. The Company is also the inventor of the Energy Generation Calculator software, which can calculate and predict energy production of a Tower given a site's local weather data.
Solar Wind Energy, Inc. is a wholly-owned subsidiary of Solar Wind Energy Tower (SWET) of Annapolis, Maryland. SWET’s intention is to establish partnerships at home and globally to generate Tower Projects and meet the growing worldwide demand for electricity. The Company does not intend to own the projects. Arizona Green Power LLC is also a subsidiary of SWET.
The Solar Wind Downdraft Tower is a hollow cylinder. It reaches into the hot, dry atmosphere heated by solar rays. The water introduced by the injection system near the top of the Tower evaporates and is absorbed by the hot, dry air. The air becomes cooler, denser, and heavier than the outside warmer air. It falls through the cylinder at speeds of up to and greater than 50 mph. It is diverted into wind tunnels surrounding the base of the Tower where turbines inside the tunnels power generators to make electricity.
SWET’s business plan includes receiving license fees for territories, development fees during construction, and recurring royalty fees based on the actual kilowatt hours produced by the Tower. The Solar Wind Energy subsidiary was established to commercialize many proven, validated technologies and construction systems into a single large Solar Wind Downdraft Tower structure that produces abundant, inexpensive electricity.
Last month, Solar Wind Energy Tower announced an update on its Tower Projects in San Luis, Arizona and San Luis Rio Colorado, Sonora, Mexico. This includes the extension of Agreements for both Tower sites. It entered into a Letter of Understanding to purchase a 1,250 acre site from a private land owner in San Luis Rio Colorado, Sonora, just across the border from the Company’s first tower site in San Luis, Arizona. SWET’s executed Letter of Understanding with the private land owner calls for definitive documents covering specific purchase terms and is subject to two conditions.
The first condition calls for the provision of all of the necessary entitlements and a Water Supply Agreement to support the operation of the Tower. The second condition calls for assistance in securing the required Power Purchase Agreements (PPA's) in support of the financing for the Tower Project.
Solar Wind Energy Tower, Inc. (SWET), closed Thursday's trading session at $0.0064, down 16.88%, on 13,024,204 volume with 75 trades. The average volume for the last 60 days is 4,302,681 and the stock's 52-week low/high is $0.003/$0.0425.
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0043, up 72.00%, on 14,981,116 volume with 152 trades. The stock’s average daily volume over the past 60 days is 3,331,368, and its 52-week low/high is $0.0008/$1.00.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
The One World Doll Project Expands Retail Presence in Texas With Fiesta Mart
One World Holdings' Prettie Girls! Dolls Make National TV Debut on Popular Fox Daytime Talk Show, "The Real"
The One World Doll Project Announces First Order From Walmart
Puget Technologies (PUGE)
The QualityStocks Daily Newsletter would like to spotlight Puget Technologies (PUGE). Today, Puget Technologies closed trading at $0.0298, up 19.20%, on 153,700 volume with 18 trades. The stock’s average daily volume over the past 60 days is 59,451, and its 52-week low/high is $0.013/$1.15.
Puget Technologies (PUGE) is primarily focused on the development and marketing of leading-edge technologies via acquisition of companies that are highly profitable or have the potential to be highly profitable in the near future. The company will target opportunities that offer consumer cost savings, energy savings, better health, and cleaner air, water, and earth.
Puget Technologies is specifically searching for companies that have proof of concept, key management in place, and a product that is ready for the market or in preparation for launch. The company will perform due diligence on the opportunities identified to determine the elements necessary to fully fund and exploit future revenue streams and asset appreciation as a public entity.
Companies acquired by Puget Technologies will gain services and products for marketing solutions as well as a platform to enter the public markets. The focus of this business model is to help private companies move forward in the market with their solutions without having to depend on funds from family and friends, venture capital or investment banking firms for necessary capital.
The growth strategy employed by Puget Technologies is designed to reduce risk exposure and leverage multiple streams of revenue. This approach is expected to lead to greater cash flows, complement the asset base, and enhance revenues in concert with minimal capital investment to gain even greater efficiency while also enhancing startup funding timelines. Disclaimer
Puget Technologies Company Blog
Puget Technologies News:
Puget Technologies Moves Company Headquarters to Englewood, CO
Puget Completes Shipping of First Orders of 3D Printers
Puget Ramps up Production
Boreal Water Collection, Inc. (BRWC)
The QualityStocks Daily Newsletter would like to spotlight Boreal Water Collection, Inc. (BRWC). Today, Boreal Water Collection, Inc. closed trading at $0.0037, up 23.33%, on 200,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 752,923, and its 52-week low/high is $0.0026/$0.03.
Boreal Water Collection, Inc. (BRWC) is an established water bottler of premium private-labeled bottled water products tailored for each client’s particular need, be it publicity, promotion, marketing, internal use or a specific event. This emphasis on customization and quality has earned Boreal an impressive reputation, evidenced by its prestigious customer base of high-end beverage brands, retailer channels, high-end hotels and restaurant chains such as H&M, Mercedes, W Hotels, Dean & Deluca, Fred Water, Wat-aah, Saks Fifth Ave, Balance Water, NY Quin Hotel, Bouchon Bakery and Princeton University, just to name a few!
Located 90 miles north New York City, Boreal’s plant is only 17 miles from its well-protected source of natural spring water, a pristine and abundant spring source deep inside the heart of the Catskill Mountains. The spring’s exceptional geological and geographical features have created the perfect environment for Boreal’s low-mineral, sodium-free and well-balanced PH water. With exclusive exploitation rights, Boreal has a confirmed volume in excess of thousands of millions of gallons.
Boreal offers a line of award-winning water products, including functional enhanced water, infused water, carbonated water, vitamins enhanced water, flavored still or sparkling, minerals enhanced water, oxygenated water, electrolyte water, distilled water, alkaline water, caffeinated water and natural spring water.
Accommodating this plentiful water supply and range of product offerings, Boreal has established a 75,000-square foot manufacturing facility. Boreal can process a full range of water and bottle types and has the most creative staff for all private labeling needs. The company offers fully integrated turnkey service, made-to-order labeling along with distinctive water bottles. In short, Boreal is a “Boutique Bottler” and is focusing on becoming the leader of this attractive niche of the growing multi-billion dollar bottled water industry. Disclaimer
Boreal Water Collection, Inc. Company Blog
Boreal Water Collection, Inc. News:
Boreal Water Collection to Exhibit at China's Largest Food Show
Boreal Water Collection Reports Continued Growth in the Third Quarter of 2014, Sales Increase by 14% While Profitability Rises by 57%
The Chatwal Hotel (NY) Agrees to Have Boreal Water Collection Produce Their Private Labeled Bottled Water
MIT Holding (MITD)
The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.06, up 20.00%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 42,853, and its 52-week low/high is $0.04/$0.31.
MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.
In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.
Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.
MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer
MIT Holding Company Blog
MIT Holding News:
MIT Holding, Inc. (MITD) Announces Profitable 3rd Quarter Financial Results
MIT Holding, Inc. (MITD) Announces Initial Revenue Generation From “Melinta AB sssi” FDA Trial
MIT Holding (MITD) and its Affiliates Receive Accreditation From Over 138 Top US Insurance Carriers
Nhale, Inc. (NHLE)
The QualityStocks Daily Newsletter would like to spotlight Nhale, Inc. (NHLE). Today, Nhale, Inc. closed trading at $0.14, up 14.75%, on 100,957 volume with 21 trades. The stock’s average daily volume over the past 60 days is 83,339, and its 52-week low/high is $0.111/$1.33.
Nhale, Inc. (NHLE) develops and sells leading-edge technology in alignment with its mission to become a recognized, premier innovator in cannabis cultivation, dispensaries, testing and scientific products. Nhale explores innovations that will position the company on the front lines of the marijuana revolution.
Nhale is currently aggressively focused on grow operations in states where cannabis is legal, or soon to be legal, such as Oregon, Alaska and Florida. As an increasing number of states move towards legalization for medical or recreational use, growers are positioned to benefit from economies of scale due to escalating demand. Focusing on candidates in the cultivation space, Nhale is poised grow into a successful, sustainable enterprise through product or company acquisition in this explosive space.
Growpod, Nhale’s self-contained grow environment technology, is one of the company’s products and an entry point into the promising cultivation technology space. Growpod uses “controlled environment agriculture” to optimize plant development, plant quality and production efficiency in all climates and seasons.
Nhale believes innovation produces profitability, especially in growth-stage organizations entering emerging industries. This belief guides Nhale’s strong commitment to develop and commercialize cutting-edge consumer-oriented products primed for rapid commercialization. The company has identified strategic industry partnerships to support this growth objective and to secure an increasing footprint in the booming marijuana market. Disclaimer
Nhale, Inc. Company Blog
Nhale, Inc. News:
Nhale Expands Acquisition Effort Toward $10 Billion Medical Marijuana Market
Nhale (NHLE) Receives $10 Million Commitment to Complete Acquisitions
Nhale (NHLE) Forecasts Revenues of More Than $30 Million in 2015 From Deals Under Consideration & Receives $10 Million Commitment to Complete Acquisitions
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.03539, up 1.99%, on 102,755 volume with 11 trades. The stock’s average daily volume over the past 60 days is 117,792, and its 52-week low/high is $0.03/$2.00.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program
IFAN Financial, Inc. (IFAN)
The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.634, up 4.28%, on 584,512 volume with 281 trades. The stock’s average daily volume over the past 60 days is 525,056, and its 52-week low/high is $0.0114/$0.675.
IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.
Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.
Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.
IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer
IFAN Financial, Inc. Company Blog
IFAN Financial, Inc. News:
IFAN Financial Announces $1 Million Private Placement
IFAN Financial Reaches Technology Development Milestones, Receives Approval From Apple and Google
IFAN Financial, Inc. (IFAN) CEO Featured in Exclusive QualityStocks Interview
Today's Top 3
First Penny Picks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) to Exhibit at China's Largest Food Show
- Cannabics Pharmaceuticals, Inc. (CNBX) engages with Mountain High Products in Colorado
- Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
- Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Ecrypt Technologies, Inc. (ECRY) Update Regarding Promotional Activity on Its Stock
- Falcon Crest Energy (FCEN) Optimistic About Prospecting in Powder River Basin
- IFAN Financial, Inc. (IFAN) Announces $1 Million Private Placement
- MIT Holding, Inc. (MITD) Announces Profitable 3rd Quarter Financial Results
- Mobile Lads Corp. (MOBO) to Launch CouBox, a Next-Generation Mobile Coupon Application
- Nhale, Inc. (NHLE) Expands Acquisition Effort Toward $10 Billion Medical Marijuana Market
- One World Holdings, Inc. (OWOO) One World Doll Project Expands Retail Presence in Texas With Fiesta Mart
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- PURE Hospitality Solutions Discusses 2015 Initiatives
- Sibling Group Holdings, Inc. (SIBE) Interviewed by TheStockRadio.com
- Start Scientific, Inc. (STSC) Signs Farmout Agreement for Flora Field, Madison County, Mississippi
- Technology Applications International, Inc. (NUUU) Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY® Awards Show at the MGM Grand in Las Vegas
- VistaGen Therapeutics, Inc. (VSTA) Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
- WRIT Media Group, Inc. (WRIT) Announces Product Updates and NASCAR Event Recap
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial